Folate supplementation, a common method of treating hyperhomocysteinemia, was found to prevent high fructose-induced NAFLD by activating the AMPK and LKB1 signalling pathways [43]. This evidence concerns the gene STK11 and metabolic dysfunction-associated steatotic liver disease.